Ventures Management V. Sanderling is 10% at ENDOCYTE INC (ECYT). They have made 5 open-market trades across 2 companies since 2006, most recently 2012-12-11.
CIK 0001267980
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
5 open-market purchases totalling $553K since 2006, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ECYT | BUY | 2011-12-20 | 2011-12-22 | $3.18 | $14K | -24.6% | -0.5% | -0.5% |
| ECYT | BUY | 2011-12-20 | 2012-01-11 | $3.18 | $141K | -24.6% | -0.5% | -0.5% |
| ECYT | BUY | 2011-12-20 | 2012-12-12 | $3.18 | $10K | -24.6% | -0.5% | -0.5% |
| ECYT | BUY | 2011-02-04 | 2011-02-08 | $6.00 | $287K | -24.6% | -0.5% | -0.5% |
| FVRL | BUY | 2006-03-07 | 2006-03-09 | $5.26 | $100K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.